Skip to main content
. 2014 Dec 5;20(1):7–12. doi: 10.1634/theoncologist.2014-0234

Figure 1.

Figure 1.

Distribution of ERBB2 alterations across diseases. Mutations, amplifications, and rearrangements involving ERBB2 were identified in 403 tumors across 27 disease types. Data are expressed as a percentage compared with the total number of tumors within that subtype in our data set.

Abbreviations: cholangio, cholangiocarcinoma; GE, gastroesophageal.